Press release
Multiple Myeloma Market Set for Robust Growth Across the 7MM | DelveInsight
Multiple Myeloma companies in the market include - Sanofi, Karyopharm Therapeutics, AbbVie, Takeda Pharmaceutical, Celgene, Bristol-Myers Squibb, RAPA Therapeutics, Pfizer, Array Biopharma, Cellectar Biosciences, BioLineRx, Celgene, Aduro Biotech, ExCellThera, Poseida Therapeutics, Molecular Partners AG, Chipscreen Biosciences, AbbVie/Genentech (Roche), Janssen Biotech, Nanjing Legend Biotech, Merck Sharp & Dohme Corp., and others.The multiple myeloma treatment paradigm is undergoing a dynamic evolution, marked by increasing therapeutic interventions by companies such as Sanofi, Karyopharm Therapeutics, AbbVie, Takeda Pharmaceutical, Celgene, Bristol-Myers Squibb, RAPA Therapeutics, Pfizer, Array Biopharma, Cellectar Biosciences, BioLineRx, Celgene, Aduro Biotech, ExCellThera, Janssen Pharmaceutical, Precision BioSciences, Takeda, Glenmark (Ichnos Sciences SA), Poseida Therapeutics, Molecular Partners AG, Chipscreen Biosciences, AbbVie/Genentech (Roche), Janssen Biotech, Nanjing Legend Biotech, Merck Sharp & Dohme Corp., and others.
DelveInsight's comprehensive report titled "Multiple Myeloma Market Insight, Epidemiology And Market Forecast - 2034 [https://www.delveinsight.com/report-store/multiple-myeloma-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" offers an in-depth market analysis from 2020 to 2034. The analysis encompasses historical data, future projections of market size, detailed epidemiological trends, an assessment of the competitive landscape, and an evaluation of current and emerging therapeutic approaches.
According to DelveInsight's findings, the total Multiple Myeloma market size across the 7MM was USD 21.5 Billion in 2023. This market is anticipated to experience continued positive growth through 2034. The United States held the largest share of the 7MM market, accounting for USD 14.5 Billion in 2023. This highlights the significant market opportunity within the United States.
Download the Multiple Myeloma market report to understand which factors are driving the Multiple Myeloma therapeutic market @ Multiple Myeloma Market Trends [https://www.delveinsight.com/sample-request/multiple-myeloma-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]
The epidemiological landscape of Multiple Myeloma in the 7MM reveals that the total incidence of the disease was approximately 76K cases in 2024. This number is projected to rise over the coming years. Notably, the highest incidence of Multiple Myeloma is observed in individuals aged 65 years and above. Furthermore, the disease is more prevalent in men than in women, with over 50% of males in the United States diagnosed with multiple myeloma.
The DelveInsight report provides a comprehensive breakdown of this epidemiological data, including total incident cases of multiple myeloma, total symptomatic cases of multiple myeloma, gender-specific cases of multiple myeloma, age-specific cases of multiple myeloma, transplant-eligible cases of multiple myeloma, and treated patient pool across all lines of therapies.
Currently, the treatment landscape for Multiple Myeloma involves a variety of approaches, including chemotherapy, immunotherapy, targeted therapy, corticosteroids, and stem cell transplantation. Significant progress has been made with the development and approval of novel therapies such as immunomodulatory drugs (IMiDs), proteasome inhibitors, and monoclonal antibodies, which have improved patient outcomes. The treatment paradigm continues to evolve with the emergence of innovative strategies like CAR-T cell therapies and bispecific antibodies, offering new hope, particularly for patients with relapsed or refractory disease.
Discover evolving trends in the Multiple Myeloma treatment landscape @ Multiple Myeloma Therapeutics Market [https://www.delveinsight.com/sample-request/multiple-myeloma-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]
Despite these significant advancements, challenges persist in the management of Multiple Myeloma, most notably the issue of disease relapse and the development of resistance to multiple drugs. The future treatment strategies are therefore focused on overcoming this resistance and achieving more durable responses. The developmental pipeline remains robust, with key pharmaceutical companies such as Regeneron (Linvoseltamab), Bristol Myers Squibb (Mezigdomide and Alnuctamab), AbbVie and Roche (VENCLEXTA), and Opna Bio (OPN-6602), among others, actively involved in bringing novel therapies to market.
Recent developments highlight ongoing innovation in multiple myeloma treatment. In February 2025, Opna Bio's OPN-6602 received FDA Orphan Drug designation for multiple myeloma, while in April 2024, the FDA approved Bristol-Myers Squibb and Bluebird Bio's ABECMA for the treatment of adult patients with relapsed or refractory multiple myeloma. These milestones, along with a robust pipeline of emerging therapies, continue to reshape the multiple myeloma treatment landscape, offering new hope for patients.
Unlock which Multiple Myeloma drug is expected to capture the largest market share in 7MM by 2032. Visit the Multiple Myeloma Market Insights [https://www.delveinsight.com/sample-request/multiple-myeloma-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]
In conclusion, the Multiple Myeloma market across the 7MM is poised for substantial growth in the coming years. This expansion is driven by a rising incidence of the disease, the increasing adoption of innovative therapies, and continuous efforts in research and development. While challenges such as relapse and drug resistance remain, the dynamic treatment landscape, marked by recent approvals and a promising pipeline, offers a positive outlook for the future of Multiple Myeloma management.
Table of Contents
1.
KEY INSIGHTS
2.
REPORT INTRODUCTION
3.
EXECUTIVE SUMMARY
4.
MULTIPLE MYELOMA MARKET OVERVIEW AT A GLANCE
5.
KEY EVENTS
6.
EPIDEMIOLOGY AND MARKET FORECAST METHODOLOGY
7.
MULTIPLE MYELOMA BACKGROUND AND OVERVIEW
8.
EPIDEMIOLOGY AND PATIENT POPULATION
9.
PATIENT JOURNEY
10.
KEY ENDPOINTS IN MULTIPLE MYELOMA
11.
MULTIPLE MYELOMA MARKETED DRUGS
12.
MULTIPLE MYELOMA EMERGING THERAPIES
13.
MULTIPLE MYELOMA: 7MM MARKET ANALYSIS
14.
MULTIPLE MYELOMA UNMET NEEDS
15.
SWOT ANALYSIS
16.
KOL VIEWS
17.
MARKET ACCESS AND REIMBURSEMENT
18.
APPENDIX
19.
DELVEINSIGHT CAPABILITIES
20.
DISCLAIMER
21.
ABOUT DELVEINSIGHT
Related Reports
Multiple Myeloma Pipeline Insight [https://www.delveinsight.com/report-store/multiple-myeloma-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]
Multiple Myeloma Pipeline Insight provides comprehensive insights about the Multiple Myeloma pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the Multiple Myeloma companies, including CASI Pharmaceuticals, Carsgen Therapeutics, Cartesian Therapeutics, Gracell Biotechnology Shanghai Co., Ltd., Sorrento Therapeutics, TeneoOne, Karyopharma Therapeutics, Arcellx, Poseida Therapeutics, Ichnos Sciences, Nerviano Medical Sciences, Bristol Myers Squib, Ascentage Pharma, Ionis Pharmaceuticals, Chongqing Precision Biotech Co., Ltd., CRISPR Therapeutics, AstraZeneca, IGM Biosciences, Novartis, GlaxoSmithKline, Innovent Biologics, Keymed Biociences, Starton Therapeutics, Takeda, Fate Therapeutics, Gilead Sciences, Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Janssen Pharmaceutical, Nanjing IASO Biotechnology Co. Ltd., GPCR Therapeutics, and Chimerix among others.
About DelveInsight
DelveInsight is a leading market research and consulting firm specializing in disease-specific insights and therapeutic market analysis. Their reports integrate real-world data, clinical trial findings, and expert interviews to deliver comprehensive industry intelligence.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Arpit Anand
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=multiple-myeloma-market-set-for-robust-growth-across-the-7mm-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Multiple Myeloma Market Set for Robust Growth Across the 7MM | DelveInsight here
News-ID: 3947578 • Views: …
More Releases from ABNewswire

3D-Engineering: How 3D Scanning Services Are Revolutionizing Modern Engineering …
Imagine being able to capture every nook and cranny of an object down to the most intricate detail. Sounds magical, right? That's the power of 3D scanning services [https://3d-engineering.net/engineering-services/3d-laser-scanning-services/] in today's engineering projects. Across industries, from automotive and construction to aerospace and healthcare, 3D scanning is transforming how things are measured, mapped, and made. Whether you're designing a new building or manufacturing precision components, 3D scanning takes you from the…

SLCLawyer: How a Separation Agreement Can Help Couples Save Thousands in Legal F …
Image: https://www.abnewswire.com/upload/2025/10/7d762be2535d9a3c2274975ea0a87869.jpg
When John and Mary decided to separate after 12 years of marriage, they thought they could handle it on their own. Money was tight, emotions were high, and the internet offered dozens of free and cheap separation agreement templates. They downloaded one, filled in the blanks, and signed it at the kitchen table.
At first, it seemed like a practical solution. They avoided paying lawyers, saved a few hundred dollars,…

Marketing Expert Tony Hayes Releases Comprehensive Guide: 26 Proven Strategies G …
Digital marketing strategist Tony Hayes has published his latest newsletter edition featuring 26 battle-tested strategies that are delivering measurable results for online entrepreneurs and marketers. The comprehensive guide covers everything from $10 microsites generating $3,000 monthly to AI automation systems landing million-dollar contracts, providing actionable insights for businesses looking to stay ahead in the rapidly evolving digital landscape.
Digital marketing expert Tony Hayes has released his latest newsletter edition, delivering 26…

Lone Wolf Siding Emerges as the Best Siding Company in New Orleans Offering Prem …
Lone Wolf Siding is the best siding company in New Orleans, Louisiana.
Image: https://www.abnewswire.com/upload/2025/09/3522ab792132a4d3ddba57316984a0de.jpg
Lone Wolf Siding, a trusted siding contractor in New Orleans, proudly announces its expanded offerings designed to protect and enhance homes across Louisiana. With a strong foundation in expert siding installation and repair, the company now provides homeowners with a full suite of exterior solutions, including patios and pergolas, all backed by exceptional craftsmanship and a 100% satisfaction…
More Releases for Bio
Human Plasma Products Market 2023: Industry Future Trends | Takeda, CSL, Grifols …
The Human Plasma Products market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with…
Gene Therapy Products Market | Advantagene, Avalanche Bio, Bluebird Bio, Cellado …
The global gene therapy products market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the gene therapy products market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Bio-based Polymethyl Methacrylate (Bio-PMMA) Market 2023 | Detailed Report
The Bio-based Polymethyl Methacrylate (Bio-PMMA) report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research.
The Bio-based Polymethyl Methacrylate (Bio-PMMA) research report…
Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary…
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the…
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the…